Lamivudine and Zidovudine
- Product NDC
- 63629-4872
- 11-digit product format
- 636294872
- Labeler code
- 63629
- Product ID
- 63629-4872_5c471fe0-c1fa-437e-b923-ab686d579f4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine and Zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA202418
- Marketing category
- ANDA
- Marketing start
- 2012-05-15
- Marketing end
- 2022-12-31
- Substance
- LAMIVUDINE; ZIDOVUDINE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-4872-1 | 63629487201 | 6 TABLET, FILM COATED in 1 BOTTLE (63629-4872-1) | 2013-01-07 | 2022-12-31 | No | No | Current |
| 63629-4872-2 | 63629487202 | 60 TABLET, FILM COATED in 1 BOTTLE (63629-4872-2) | 2022-02-08 | 2022-12-31 | No | No | Current |
| 63629-4872-3 | 63629487203 | 4 TABLET, FILM COATED in 1 BOTTLE (63629-4872-3) | 2022-02-08 | 2022-12-31 | No | No | Current |